Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance
项目 2 - 将小胶质细胞激活与血脑屏障完整性和神经认知功能相关联
基本信息
- 批准号:10659199
- 负责人:
- 金额:$ 79.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project: 2 Summary/Abstract
Project 2 continues our focus on brain imaging studies in human SLE to investigate mechanisms of cognitive
dysfunction in patients with this disorder. The proposed study leverages the information gained in the last
funding cycle: the presence of consistent elevations in resting metabolic activity (a proxy for local synaptic
function) in the hippocampus of SLE patients, which correlated with anti DNA receptor antibody (DNRAb) titers
and with performance on cognitive test battery. In the next funding cycle, we plan to use multimodal PET and
MRI imaging tools to determine the mechanistic basis for cognitive dysfunction in this disorder. New
experimental evidence from Project 1 implicates microglial (MG) activation in the hippocampal neurotoxic
response to DNRAb. We will therefore use [11C]-PBR28 PET to assess this phenomenon in SLE patients
compared to healthy volunteer subjects. To this end, radiotracer uptake will be quantified in the hippocampus
and other metabolically active SLE-related brain regions. Using a longitudinal design, we will evaluate regional
MG activation over a two-year period, and determine how these changes relate to concurrent assessments of
cognitive functioning, DNRAb titers, and resting metabolic activity measured in the same subjects. Likewise,
we will use a quantitative MRI approach to evaluate BBB permeability in the hippocampus and in the other
SLE-related brain regions. Changes in this measure will similarly be compared with concurrent serological and
cognitive assessments, as well as with the other imaging descriptors of the underlying disease process. The
broad applicability of this approach may be limited, however, by the invasiveness of some of the imaging
methods. To make these assessments more clinically accessible, we will lastly explore the use of newer non-
invasive imaging tools as alternative disease markers. In summary, the multimodal imaging approach in
Project 2 will provide objective metrics for the assessment of new treatment strategies for SLE-CI.
项目:2摘要/摘要
项目2继续关注人类SLE中的脑成像研究以研究认知机制
这种疾病患者的功能障碍。拟议的研究利用了最后的信息
资金周期:静息代谢活动中存在一致的升高(局部突触的代理
功能)在SLE患者的海马中,与抗DNA受体抗体(DNRAB)滴度相关
并具有认知测试电池的性能。在下一个资金周期中,我们计划使用多模式宠物和
MRI成像工具确定该疾病认知功能障碍的机理基础。新的
项目1的实验证据暗示了海马神经毒性中的小胶质细胞(MG)激活
对DNRAB的反应。因此,我们将使用[11C] -PBR28 PET评估SLE患者的这种现象
与健康的志愿者相比。为此,将在海马中量化放射性示意剂的摄取
以及其他代谢活跃的与SLE相关的大脑区域。使用纵向设计,我们将评估区域
MG在两年内激活,并确定这些变化与同时评估有关
认知功能,DNRAB滴度和在同一受试者中测得的静息代谢活性。同样地,
我们将使用定量MRI方法来评估海马中的BBB渗透性
与SLE相关的大脑区域。该措施的变化将与并发的血清学和
认知评估以及基本疾病过程的其他成像描述符。这
但是,由于某些成像的侵入性,这种方法的广泛适用性可能受到限制
方法。为了使这些评估在临床上更容易访问,我们将探索使用新的非 -
侵入性成像工具作为替代性疾病标记。总而言之,多模式成像方法
项目2将为评估SLE-CI的新治疗策略提供客观指标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
MEGGAN MACKAY的其他基金
Treatment of SLE with Ajulemic Acid, a Non-Psychoactive Cannabinoid Derivative
用 Ajulemic Acid(一种非精神活性大麻素衍生物)治疗 SLE
- 批准号:87430758743075
- 财政年份:2013
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Treatment of SLE with ajulemic acid, a non-psychoactive cannabinoid derivative
用 ajulemic Acid(一种非精神活性大麻素衍生物)治疗 SLE
- 批准号:85798648579864
- 财政年份:2013
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
CLINICAL TRIAL: RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PHASE II TRIAL OF CTLA4IG
临床试验:CTLA4IG 的随机、双盲、对照、II 期试验
- 批准号:81672668167266
- 财政年份:2010
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
FUNCTIONAL MRI OF COGNITIVE AND EMOTIONAL ABNORMALITIES IN PATIENTS WITH LUPUS
狼疮患者认知和情绪异常的功能 MRI
- 批准号:81672468167246
- 财政年份:2010
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
CLINICAL TRIAL: PHASE II TRIAL OF CTLA4IG IN THE TREATMENT OF LUPUS NEPHRITIS
临床试验:CTLA4IG 治疗狼疮性肾炎的 II 期试验
- 批准号:79519617951961
- 财政年份:2009
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
FUNCTIONAL MRI OF COGNITIVE AND EMOTIONAL ABNORMALITIES IN PATIENTS WITH LUPUS
狼疮患者认知和情绪异常的功能 MRI
- 批准号:79519397951939
- 财政年份:2009
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance
项目 2 - 将小胶质细胞激活与血脑屏障完整性和神经认知功能相关联
- 批准号:1045433110454331
- 财政年份:2008
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance
项目 2 - 将小胶质细胞激活与血脑屏障完整性和神经认知功能相关联
- 批准号:1021451410214514
- 财政年份:2008
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Imaging antibody effects in SLE patients
成像抗体对 SLE 患者的影响
- 批准号:87411888741188
- 财政年份:2008
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance
项目 2 - 将小胶质细胞激活与血脑屏障完整性和神经认知功能相关联
- 批准号:1002460210024602
- 财政年份:2008
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
相似国自然基金
优先流对中俄原油管道沿线多年冻土水热稳定性的影响机制研究
- 批准号:42301138
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开放空间内部特征对公共生活行为的复合影响效应与使用者感知机理研究
- 批准号:52308052
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
市场公平竞争与企业发展:指标测度、影响机理与效应分析
- 批准号:72373155
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
气候变暖对青藏高原高寒草甸土壤病毒多样性和潜在功能的影响
- 批准号:32301407
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高温胁迫交叉锻炼对梭梭幼苗耐旱性影响的分子机理研究
- 批准号:32360079
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:1067834110678341
- 财政年份:2023
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Using Natural Mouse Movement to Establish a Developmental "Biomarker" for Corticospinal Damage
利用自然小鼠运动建立皮质脊髓损伤的发育“生物标志物”
- 批准号:1066780710667807
- 财政年份:2023
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Imaging transcriptomics across developmental stages of early psychotic illness
早期精神病发展阶段的转录组学成像
- 批准号:1066478310664783
- 财政年份:2023
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Disruption of spinal circuit early development after silencing En1/Foxp2 interneurons
沉默 En1/Foxp2 中间神经元后脊髓回路早期发育中断
- 批准号:1075285710752857
- 财政年份:2023
- 资助金额:$ 79.61万$ 79.61万
- 项目类别:
Cross-modal plasticity after the loss of vision at two early developmental ages in the posterior parietal cortex: Adult connections, cortical function and behavior.
后顶叶皮质两个早期发育年龄视力丧失后的跨模式可塑性:成人连接、皮质功能和行为。
- 批准号:1075165810751658
- 财政年份:2023
- 资助金额:$ 79.61万$ 79.61万
- 项目类别: